George Soros's COAG Position Overview
George Soros (via Soros Fund Management LLC) currently holds 25,000 shares of Hemab Therapeutics Holdings, Inc. (COAG) worth $918,250, representing 0.01% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, George Soros has initiated a new position in COAG, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
George Soros's Hemab Therapeutics Holdings (COAG) Holding Value Over Time
Track share changes against reported price movement
Quarterly Hemab Therapeutics Holdings (COAG) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +25,000 | New Buy | 25,000 | $36.73 |
George Soros's Hemab Therapeutics Holdings Investment FAQs
George Soros first purchased Hemab Therapeutics Holdings, Inc. (COAG) in Q2 2026, acquiring 25,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Hemab Therapeutics Holdings, Inc. (COAG) for 1 quarters since Q2 2026.
George Soros's largest addition to Hemab Therapeutics Holdings, Inc. (COAG) was in Q2 2026, adding 25,000 shares worth $918,250.
According to the latest 13F filing for Q2 2026, George Soros's firm, Soros Fund Management LLC, owns 25,000 shares of Hemab Therapeutics Holdings, Inc. (COAG), valued at approximately $918,250.
As of the Q2 2026 filing, Hemab Therapeutics Holdings, Inc. (COAG) represents approximately 0.01% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Hemab Therapeutics Holdings, Inc. (COAG) was 25,000 shares, as reported at the end of Q2 2026.